Citadel Advisors LLC 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:19 am Sale | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Citadel Advisors LLC | 20,081,572 3.700% | -10,848,814 (-35.07%) | Filing |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Citadel Advisors LLC | 30,930,386 8.900% | -202,605 (-0.65%) | Filing |
| 2020-07-10 4:02 pm Purchase | 2020-07-01 | 13G | Mereo BioPharma Group plc MREO | Citadel Advisors LLC | 31,132,991 8.900% | 31,132,991 (New Position) | Filing |